Additional Post Hoc Analysis and Clinical Data Collection
BNA™
1 other identifier
observational
55
1 country
2
Brief Summary
The purpose of this study is to collect additional Investigational cognitive tasks and additional clinical data for subjects tested with ElMindA's Brain Network Activation (BNA™).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2016
Typical duration for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2016
CompletedFirst Submitted
Initial submission to the registry
August 1, 2016
CompletedFirst Posted
Study publicly available on registry
August 9, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2018
CompletedJune 6, 2019
June 1, 2019
2.2 years
August 1, 2016
June 5, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
engineering development according to clinical assessments
The study is designed to collect data that will aid in future scientific and engineering exploration of correlations between clinical assessments and BNA scores. The results are primarily intended for scientific inquiry and engineering development purposes.
2 years
Eligibility Criteria
Subjects who completed a BNA test with the Auditory Oddball Task, from both genders, aged 3-99 years.
You may qualify if:
- Completed a BNA test in the past
- Able to speak, read and understand English sufficiently to understand the nature of the study, and to allow completion of all study assessments.
- Willingness to participate
You may not qualify if:
- Significant Sensory deficit
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- ElMindA Ltdlead
Study Sites (2)
ElMindA
Glenview, Illinois, 60026, United States
Premier Psychiatric Group
Lincoln, Nebraska, 68526, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mark Skopin, PhD
ElMindA Ltd
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 1, 2016
First Posted
August 9, 2016
Study Start
July 1, 2016
Primary Completion
September 1, 2018
Study Completion
October 1, 2018
Last Updated
June 6, 2019
Record last verified: 2019-06
Data Sharing
- IPD Sharing
- Will not share